Progyny, Inc.

NasdaqGS:PGNY Voorraadrapport

Marktkapitalisatie: US$1.2b

Progyny Toekomstige groei

Future criteriumcontroles 2/6

Progyny zal naar verwachting groeien in winst en omzet met respectievelijk 19.9% en 7.8% per jaar. De winst per aandeel zal naar verwachting groeien met 21.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 17.1% zijn.

Belangrijke informatie

19.9%

Groei van de winst

21.2%

Groei van de winst per aandeel

Healthcare winstgroei20.9%
Inkomstengroei7.8%
Toekomstig rendement op eigen vermogen17.1%
Dekking van analisten

Good

Laatst bijgewerkt13 Nov 2024

Recente toekomstige groei-updates

Recent updates

Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Nov 21
Progyny's (NASDAQ:PGNY) Solid Earnings Have Been Accounted For Conservatively

Progyny: After A Terrible Year, I'm Out (Rating Downgrade)

Nov 18

Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Oct 21
Here's What's Concerning About Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny: Poor Year Raises Concerns For Future (Downgrade)

Oct 15

Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Sep 29
Progyny, Inc.'s (NASDAQ:PGNY) Stock Retreats 28% But Earnings Haven't Escaped The Attention Of Investors

Progyny: Downgrading As Uncertainties Increase

Aug 15

Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

Aug 11
Progyny, Inc. (NASDAQ:PGNY) Stocks Pounded By 25% But Not Lagging Market On Growth Or Pricing

At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Jul 20
At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely?

Progyny: Recent Stock Decline Provides Buying Opportunity

Jul 12

Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Jun 23
Progyny's (NASDAQ:PGNY) Returns Have Hit A Wall

Progyny: At This Price, Secular Tailwinds Are Too Compelling To Ignore

Jun 10

Progyny: No Change To Long-Term Outlook

Jun 04

Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Apr 29
Why We're Not Concerned About Progyny, Inc.'s (NASDAQ:PGNY) Share Price

Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Apr 03
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)?

Progyny: Long-Term Outlook Remains Positive, Reiterate Buy

Mar 15

Progyny: Long-Term Thesis Still Intact

Mar 09

Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Mar 01
Progyny's (NASDAQ:PGNY) Returns On Capital Are Heading Higher

Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Jan 07
Progyny, Inc.'s (NASDAQ:PGNY) P/E Still Appears To Be Reasonable

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Dec 11
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Nov 08
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY)

Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

Aug 24
Is Progyny, Inc. (NASDAQ:PGNY) Potentially Undervalued?

There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Aug 06
There's Been No Shortage Of Growth Recently For Progyny's (NASDAQ:PGNY) Returns On Capital

Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

May 06
Progyny (NASDAQ:PGNY) Is Looking To Continue Growing Its Returns On Capital

When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Jan 25
When Should You Buy Progyny, Inc. (NASDAQ:PGNY)?

Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Dec 12
Progyny (NASDAQ:PGNY) Shareholders Will Want The ROCE Trajectory To Continue

Winst- en omzetgroeiprognoses

NasdaqGS:PGNY - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261,314811982028
12/31/20251,1645317818510
12/31/20241,1465216818710
9/30/20241,13957160165N/A
6/30/20241,13363171174N/A
3/31/20241,10861190194N/A
12/31/20231,08962185189N/A
9/30/20231,03352199203N/A
6/30/202395749165169N/A
3/31/202387343109113N/A
12/31/2022787307780N/A
9/30/2022700423538N/A
6/30/2022617463841N/A
3/31/2022551561214N/A
12/31/2021501662426N/A
9/30/2021473902224N/A
6/30/2021450781415N/A
3/31/2021386582425N/A
12/31/2020345463536N/A
9/30/202031032124N/A
6/30/2020272-101115N/A
3/31/2020264-51317N/A
12/31/2019230-9-4-2N/A
9/30/2019194-678N/A
6/30/2019160112N/A
3/31/2019130-400N/A
12/31/2018105-622N/A
12/31/201749-13N/A-9N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei PGNY ( 19.9% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van PGNY ( 19.9% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.4% per jaar).

Hoge groeiwinsten: De winst van PGNY zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van PGNY ( 7.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).

Hoge groei-inkomsten: De omzet van PGNY ( 7.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen PGNY zal naar verwachting over 3 jaar laag zijn ( 17.1 %).


Ontdek groeibedrijven